AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02641405 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Inactive Equistasi
Description: Inactive Equistasi will be given to every patient in the form of three patches to be placed at C7 and at the gastrocnemial junction of both legs.
Study NCT01710059 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inhaled Corticosteroid Mobile Phone Application
Description: The Inhaled Corticosteroid Mobile Phone Application will be used to provide virtual doctor supervision, immediate feedback, and positive reinforcement for taking inhaled corticosteroid medication as indicated.
Study NCT01710059 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Beta2-adrenergic agonist Mobile Phone Application
Description: The Beta2-adrenergic agonist Mobile Phone Application will be used to track real time patterns of use of beta2-adrenergic agonist medication.
Study NCT03922022 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EIM exercise classes and intervention
Description: This is a complex intervention. On recruitment, they will be seen by a nurse and counselled using motivational technique. They will then undergo a 12-week class. The exercise levels will be regularly feedback to the patients by use of mobile devices and trackers. Peer support is formed during the 12-week class. Resources to continue exercise will be provided to patients. Regular monitoring of physical improvement will be feedback to patients to encourage continued exercise.
Study NCT02022722 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trigger Point Injections Triamcinolone Acetonide, Bupivacaine Hydrochloride
Description: The mixture is injected into the levator muscles, with half the volume on each side of the pelvic musculature.
Study NCT01390428 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Grazoprevir
Description: Part 1: oral morning dose of 200 mg daily for 10 days Part 2: oral morning dose of 100 mg daily for 10 days Part 3: oral morning dose of 50 mg daily for 10 days
Study NCT01051440 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lisdexamfetamine
Description: Start at 20 mg daily. Increased to a maximum of 40 mg daily. Can be decreased in 10 mg increments.
Study NCT01051440 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will receive placebo matched to lisdexamfetamine.
Study NCT03264534 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: limbal relaxing incisions
Description: Manually performed surgical procedure
Study NCT03264534 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: astigmatic keratotomy
Description: femtosecond laser guided surgical procedure
Study NCT04780633 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Precede-Proceed based Training Program on Genital Hygiene Behaviors
Description: A Training Program for Genital Hygiene Behaviors prepared in line with the Precede-Proceed model was presented to the women in the experimental group. The trainings started one week after the pre-test data were collected and were conducted in a total of 5 sessions, each lasting an average of 40 minutes, once a week. At the end of the five-week training, a post-test was applied. In order to determine the behavior changes of the women in the experimental group, a follow-up test was applied 4 weeks after the training ended. At the end of the training, women were given a training booklet prepared by the researcher.
Study NCT02352376 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional ventilator
Description: A ventilator designed for invasive ventilation was used has mode non-invasive ventilation with leakage compensation (50% of the predetermined tidal volume).
Study NCT02022722 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic Rehabilitation
Description: Pelvic floor massage will be performed on a weekly basis by a licensed physiotherapist specialized in pelvic floor pelvic therapy
Study NCT02352376 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Specific ventilator
Description: A ventilator was used designed for non-invasive ventilation has an algorithm that calculates the loss of pressure and automatically compensates for leak
Study NCT03253263 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OHB-607
Description: Participants will receive intravenous infusion of OHB-607 from birth up to PMA 29 weeks + 6 days.
Study NCT02906020 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: venglustat GZ/SAR402671
Description: Pharmaceutical form: capsule Route of administration: oral
Study NCT02906020 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form: capsule Route of administration: oral
Study NCT02928601 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ondansetron
Description: After spinal anesthesia, half of the patients will be given intravenous 8 mg ondansetron.
Study NCT02928601 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Saline
Description: After spinal anesthesia, half of the patients will be given intravenous 2 mlt saline.
Study NCT02984644 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin
Description: Three 5-hour measurements (after dapagliflozin 10mg administration) of endogenous glucose production (EGP) will be performed on separate days.
Study NCT02984644 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Three 5-hour measurements (after placebo administration) of endogenous glucose production (EGP) will be performed on separate days.
Study NCT01530711 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Terlipressin and albumin
Description: Terlipressin dose: 2mg/24h, it will be modified depending on: Arterial pressure increase \< 10 mmHg and the creatinine values decrease \<25%, it will be increased every 8 hours until reaching an increase of at least 10mmHg arterial pressure or a creatinine decrease of the 25%.~Albumin: Initial dose (first day) of 1g/Kg (up to a maximum of 100g) and the following days from 20 to 40 g/day.
Study NCT00182533 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sertraline
Description: 25 - 200 mg/day x 16 weeks
Study NCT00182533 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 25 - 200 mg/day x 16 weeks
Study NCT02986347 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous regional anesthesia (Bier)
Description: Intravenous regional anesthesia (Bier Technique)
Study NCT02986347 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local anesthesia with adrenaline
Description: local anesthesia with adrenaline without limber garroting (Lalonde Technique)
Study NCT03054285 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Description: Participants assigned to the experimental arm will receive a seven day course of levetiracetam for post-traumatic brain injury
Study NCT01738256 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wellbeing intervention (ACT)
Description: The intervention is based on principles of acceptance-commitment therapy (ACT). It aims to increase psychological flexibility through different exercises that are developed for improving skills of being present, dealing with thoughts and feelings, as well as support clarifying individual values and value-based actions. In addition exercises for relaxation, physical activity, and mindful eating are provided. The content of intervention for face-to-face and mobile groups is similar but delivery method is different.
Study NCT01738256 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wellbeing intervention (Internet)
Description: The intervention is Duodecim Virtual Health Check and Coaching where the subject gets feedback based on his/her health information and is provided with different weekly tasks regarding lifestyle changes. The tasks are developed based on principles of cognitive behaviour therapy (CBT).
Study NCT01738256 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No intervention
Description: No intervention
Study NCT00781924 — intervention group
Intervention type: PROCEDURE
Intervention: biopsy
Description: ultrasound guided biopsy of tumors.
Study NCT02701062 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: AtriClip® Gillinov-Cosgrove™ LAA Exclusion Systems
Study NCT02701062 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anticoagulation Therapy
Description: Anticoagulation Therapy- Standard of Care at the discretion of the Investigator.
Study NCT02641587 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CHTP 1.2
Description: Ad libitum use of the CHTP 1.2 for 5 days in confinement followed by 85 days in an ambulatory setting.
Study NCT02641587 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CC
Description: Ad libitum use of subject's own preferred non-menthol brand of CC for 5 days in confinement followed by 85 days in an ambulatory setting.
Study NCT03207308 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Description: 200,000 IU of preformed vitamin A
Study NCT04692272 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise in the XBOX kinect
Description: The XBOX group performed exercise for 60 min, three times/week, for 6 weeks, using the Xbox Kinect game Your Shape Fitness evolved. This game was chosen because it simulates an environment with a variety of physical activities, in which the majority can be practiced by older adults. The activities were carried out individually. The game activities selected for the physical activity sessions were: 1) Zen-Develop it (stretching, balance and flexibility activities, similar to Yoga); 2) Pump it (to fill balls until they burst); 3) Wall Breaker (to break blocks, similar to boxing); 4) Kick it (soccer activity); 5) Hurricane (to lift the balls off the floor and not let them fall); 6) Stack in Up (balance activity).
Study NCT00729300 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 0mg daily
Study NCT00729300 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: disulfiram
Description: 250mg daily
Study NCT00698282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1981
Description: Oral tablet, 250 mg single dose
Study NCT00698282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1981
Description: Suspension, 15, 75, 1000 and 2000 mg
Study NCT00698282 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04200222 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: cadmium, lead and vanadium measurements and compare
Description: The method developed by Aliyev et al. was used for preparing the samples for analysis (1).~The three metals (cadmium, lead and vanadium) were measured using inductively coupled plasma-mass spectrometry (Thermo Scientific ICAPQc, USA).~1. Ovayolu A, Ovayolu G, Karaman E, Yuce T, Ozek MA, Turksoy VA. Amniotic fluid levels of selected trace elements and heavy metals in pregnancies complicated with neural tube defects. Congenit Anom (Kyoto). 2019:10.1111/cga.12363.
Study NCT05227781 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-Citrulline
Description: 8 weeks of L-Citrulline supplementation (10 grams/day)
Study NCT05227781 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 8 weeks of Placebo (maltodextrin; 10 grams/day)
Study NCT03167853 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: humanized anti-PD-1 monoclonal antibody
Description: humanized anti-PD-1 monoclonal antibody(JS001) is a programmed death-1 (PD-1) immune checkpoint inhibitor antibody, which selectively interferes with th combination of PD-1 with its ligands, PD-L1 and PD-L2, resulting in the activitation of lymphocytes and elimination of malignancy theoretically.
Study NCT01828086 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CJM112
Description: Monoclonal antibody
Study NCT01828086 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Secukinumab
Description: Monoclonal antibody
Study NCT01828086 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Liquid for subcutaneous injection without active drug.
Study NCT03234946 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CAIPaDi
Description: Patients are attended in 1 day by 9 specialists (endocrinologist, diabetes educators, nutritionist, psychologist, physical activity specialist, foot care and ophthalmologist). They are attended in 4 monthly visits. After the initial phase, patients come back to the Center at 1 and 2 years for evaluation and reinforcement
Study NCT04293952 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance, Resistance, Aerobic, Cognition Exercises (BRACE)
Description: BRACE is a combination of different exercises including Balance, Resistance, Aerobic, Cognition for fall risk reduction and to mobility in the elderly.
Study NCT04293952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Balance Resistance Exercise (BRE)
Description: this is the simple conventional treatment for the elderly in balance problems including warm-up, resistance exercises and cool-down exercises.
Study NCT02875145 — intervention group
Intervention type: PROCEDURE
Intervention: Cataract surgery
Study NCT03709108 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: SI-Informed Bolus Calculator
Description: The SI-Informed Bolus Calculator will be used to dose the dinner meal insulin bolus during the Experimental Admission
Study NCT02634424 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MyPKFiT
Description: Adjustment of the treatment dose using a decision support software according to the PK values
Study NCT01547624 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neck specific exercises
Description: Neck specific exercises 2 times/week for 3 month at a physiotherapist. Home exercises.
Study NCT00610909 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine CR
Description: Those in the active treatment group will receive doses of Paxil CR in increments of 12.5 mg daily for the first week and increased at 12.5 mg increments at visit weeks to a maximum of 50 mg daily, as determined by the investigator. The investigator will adjust dosage based on clinical response. Following the completion of the double-blind phase, patients on placebo and non-responders to the study drug will be tapered off the study drug back to 0 over 2 weeks, and they will be referred to their Primary Care Physician, Internist or Gastroenterologist to be prescribed treatment for Irritable Bowel Syndrome.
Study NCT00610909 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT04484389 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: Exercise protocol according to Ipaq will be prepared for 30 patients with chronic disease . Exercise protocol; warm-up exercises include, stretching exercises, postural exercises, aerobic exercise and cooling exercises. People will practice the exercises 3 days a week for 6 weeks. People will need to reserve 30 minutes a day for this study.
Study NCT04484389 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise brochure
Description: General exercise protocol will be prepared and given to the control group as a brochure
Study NCT02577003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipragliflozin
Description: 50 mg tablet administered orally
Study NCT02577003 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo to ipragliflozin tablet administered orally
Study NCT02577003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Description: Background medication; 50 mg tablet administered orally
Study NCT02577003 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sitagliptin
Description: Background medication; 50 mg tablet administered orally
Study NCT03210519 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Eleutherococcus senticosus
Description: taken orally once/day for 90 days
Study NCT03210519 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: taken orally once/day for 90 days
Study NCT04030689 — intervention group
Intervention type: OTHER
Intervention: data collected from patient file
Description: socio-demographics, previous HIV testing history, history of HIV contamination, clinics HIV related data will be collected for each patient who notified his non-objection to participate to this non interventional study.
Study NCT00708851 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LCD Solution with NB-UVB Phototherapy
Description: LCD Solution: 2 applications / day~NB-UVB Phototherapy: 3 light sessions / week
Study NCT00708851 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NB-UVB Light Device (311-315 nm)
Description: NB-UVB Phototherapy: 3 light exposures / week
Study NCT00708851 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NB-UVB Light Device (311-315 nm)
Description: NB-UVB Phototherapy: 3 light exposures / week
Study NCT03253432 — intervention group
Intervention type: OTHER
Intervention: Genetic testing
Description: Targeted next-generation sequencing for familial hypercholesterolemia causative mutations
Study NCT00311415 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Meningococcal C conjugate vaccine
Description: Meningococcal conjugate vaccine, active comparator.~Groups 1 to 3 were given a booster dose in the second year of life at 12-16 months of age
Study NCT00311415 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal C conjugate vaccine
Description: Meningococcal conjugate vaccine, active comparator.~Groups 1 to 3 were given a booster dose in the second year of life at 12-16 months of age
Study NCT00534053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mailed Educational Reminder
Description: 1 page educational reminder that reminds the patient to return their FOBT cards back to the VA laboratory. In addition, it also contains reasons why colon cancer screening is important.
Study NCT02888223 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCT800
Study NCT02888223 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Xyntha
Study NCT00737828 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Perioperative care pathway guided by CPX results
Description: * AT > 11ml/min/kg no myocardial ischaemia or Ve/VO2 \<35 - Level 1 Ward Care~* AT > 11ml/min/kg with myocardial ischaemia or Ve/VO2 >35 - Level 2/3 (ITU) Critical Care Unit~* AT \<11mls/min/kg - Level 2/3 Critical Care Unit~* AT \<8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure
Study NCT03795662 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Obervational
Study NCT02017626 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mCyp c 1
Description: 2 patient groups with different doses of allergen.
Study NCT00737828 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Perioperative care pathway guided by CPX results
Description: * AT > 11ml/min/kg no myocardial ischaemia or Ve/VO2 \<35 - Level 1 Ward Care~* AT > 11ml/min/kg with myocardial ischaemia or Ve/VO2 >35 - Level 2/3 (ITU) Critical Care Unit~* AT \<11mls/min/kg - Level 2/3 Critical Care Unit~* AT \<8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure
Study NCT04182113 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS Stimulation
Description: rTMS is an electromagnetic device that provides non-invasive stimulation to the cortex or a sham placebo stimulation that mimics properties without stimulation.
Study NCT03373357 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Patient not SAHOS
Description: Phone consultation in 1 month, 3mois, then every 6 months, and an annual visit.~* Cardiovascular events arisen during the duration of the study~* Modifications of the lifestyle: alcohol, physical activity~* Weight~* Clinical measure of the PA~* Clinical examination~* The collection of the cardiovascular events arisen during the duration of the study will be realized for all the inclusive patients
Study NCT03373357 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Patient SAHOS sailed by the ventilation in PPC and not sailed
Description: Questionnaire of subjective evaluation of diurnal slumber: scale of Epworth and search for appearance of at least 2 of the following symptoms: sleep not salvage dealer, night-breathlessnesses, multiple awakenings, fatigue, disordersconfusions, nycturie, snore.~* Questionnaire of evaluation of the global quality of life of the SAHOS~* Appearance of new cardiovascular risk factors~* Cardiovascular events arisen during the duration of the study~* Modification of the current treatments~* Modifications of the lifestyle: alcohol, physical activity~* Weight~* Clinical measure of the PA~* Clinical examination~* The collection of the cardiovascular events arisen during the duration of the study will be realized for all the inclusive patients
Study NCT02092649 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega-3 Complete
Study NCT02092649 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Pill
Study NCT04182113 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham rTMS Stimulation
Description: rTMS is an electromagnetic device that provides non-invasive stimulation to the cortex or a sham placebo stimulation that mimics properties without stimulation.